Clik here to view.
Establishment of Mitsui Chemicals Thailand
TOKYO Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: Tsutomu Tannowa) announced that it established Mitsui Chemicals (Thailand) Co., Ltd. in Bangkok, Thailand on April 3, 2017. With...
View ArticleClik here to view.
Lombard Medical and MicroPort Scientific Corporation Finalize Strategic...
OXFORDSHIRE, U.K. & SHANGHAI Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair, and MicroPort Scientific Corporation (HK: 0853), a leading...
View ArticleClik here to view.
Ra Medical Systems的Pharos皮肤激光系统已在中国获得核准
加州卡尔斯巴德 (美国商业资讯) — 心血管及皮肤病准分子激光及导管生产商Ra Medical Systems, Inc.的Pharos准分子激光系统已获得中华人民共和国FDA (CFDA)核准，用于治疗银屑病、白癜风和其他皮肤病。 Ra Medical Systems正在中国积极寻找经销商。 Pharos在美国、中东和亚洲部分市场拥有十年以上经过验证的临床成功，已开展数百万例治疗。...
View ArticleClik here to view.
Meiji Seika and Eisai Enter into a Collaboration for the Development and...
MILAN Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS)...
View ArticleClik here to view.
Sosei Subsidiary Heptares to Receive US$12 Million Milestone Payment from...
TOKYO Sosei Group Corporation (“Sosei”; TSE Mothers Index:4565) reported that its subsidiary, Heptares Therapeutics (“Heptares”) has announced that it has achieved an important milestone in its...
View ArticleClik here to view.
Finch Therapeutics and Takeda Announce Global Collaboration to Develop...
OSAKA, Japan & SOMERVILLE, Mass. Finch Therapeutics, a privately held microbiome engineering company, and Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), today announced a global...
View ArticleClik here to view.
Corindus宣布，首批采用CorPath® GRX系统的机器人PCI辅助手术在亚洲完成
马萨诸塞州沃尔瑟姆 — (美国商业资讯) — 精准血管机器人的领先开发者Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS)今天宣布，首批采用其CorPath GRX系统的机器人辅助PCI手术在亚洲完成。上述手术之一由阜外医院向中国介入治疗会议的8000多位与会者实况转播。今年在中国北京召开的此次年会是亚太区最大的介入心内科会议。...
View ArticleClik here to view.
Takeda Completes Enrollment of More Than 20,000 Children and Adolescents in...
OSAKA, Japan Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16 in its global,...
View ArticleClik here to view.
Certara’s d3 Medicine Partners with the Australian Department of Defence to...
PRINCETON, N.J. Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that its d3...
View ArticleClik here to view.
Acelity Names R. Andrew Eckert President and Chief Executive Officer
SAN ANTONIO Acelity L.P. Inc., a leading global advanced wound care company, today announced that it has named R. Andrew Eckert as President and Chief Executive Officer. Eckert succeeds Joseph...
View ArticleClik here to view.
Simulations Plus Finalizes Distributor Agreement With Korean Company
LANCASTER, Calif. Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling & simulation solutions for the pharmaceutical, biotechnology, and chemicals industries, today announced...
View ArticleClik here to view.
Aurinia Announces Development Plans for Voclosporin in Europe and Japan
VICTORIA, British Columbia Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), today announced the outcome of discussions with both the European Medicines Agency (EMA)...
View ArticleClik here to view.
U.S. FDA Approves Increased Compassionate Use Patient Cases and Sites for...
VALENCIA, Calif. & PERTH, Australia & LONDON The U.S. Food and Drug Administration has approved a further increase in the number of patients who can be treated in the United States with the...
View ArticleClik here to view.
Chi-Med Presented Pre-clinical Data for Fruquintinib and Sulfatinib at the...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq:HCM) presented pre-clinical data for fruquintinib and sulfatinib at the American Association for Cancer Research (“AACR”) Annual...
View ArticleClik here to view.
PeptiDream Announces Discovery Collaboration Agreement With Janssen
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO: 4587) announced today that it has entered into a multi-target discovery and optimization collaboration...
View ArticleClik here to view.
Fresenius Medical Care AG & Co. KGaA发布2016财年 20-F表格
德国巴特洪堡 (美国商业资讯)全球最大的透析产品和服务提供商Fresenius Medical Care AG & Co. KGaA（简称“公司”或“Fresenius Medical...
View ArticleClik here to view.
Low-Level Light Therapy Accelerates Hair Growth in Chemotherapy Patients
BOCA RATON, Fla. Photobiomodulation therapy, or low-level light therapy (LLLT), has been shown to accelerate hair recovery by 2.6x in patients with chemotherapy-induced alopecia (CIA), according to...
View ArticleClik here to view.
joimax® Celebrates Its 10th Anniversary with 900 Users in China and Reports a...
IRVINE, Calif. joimax®, the German-based market leader of technologies and training methods for endoscopic minimally invasive spinal surgery, recently celebrated its 10-year anniversary in China...
View ArticleClik here to view.
フレゼニウス メディカル ケアがフォーム20-Fの2016会計年度報告書を公表
独バートホンブルク （ビジネスワイヤ） 透析用製品／サービスを提供する世界最大企業のフレゼニウス メディカル ケア（「当社」または「フレゼニウス メディカル...
View ArticleClik here to view.
Ansell Launches VivaGel® Condom in Canada
MELBOURNE, Australia Starpharma Holdings Ltd (ASX:SPL, OTCQX:SPHRY) is pleased to announce the VivaGel® condom has been launched in Canada by Ansell (ASX:ANN) under the LifeStyles® Dual Protect™...
View Article